Metabolic hallmarks of type 2 diabetes compromise T cell function

Area of Science:

• Immunology
• Metabolism
• Endocrinology

Background:

• Type 2 diabetes (T2D) is characterized by systemic metabolic dysregulation.
• T2D significantly impairs T cell immunity, affecting immune responses and homeostasis.
• Metabolites play crucial roles in T cell biology as energy sources, signaling molecules, and epigenetic regulators.

Purpose of the Study:

• To review how T2D metabolic hallmarks reprogram T cell metabolism and function.
• To examine the immunomodulatory effects of T2D therapies on T cells.
• To elucidate the interplay between T2D-induced metabolic changes and drug-induced immunomodulation.

Main Methods:

• Literature review synthesizing current evidence.
• Analysis of metabolic reprogramming in T cells due to hyperglycemia, hyperinsulinemia, and dyslipidemia.
• Examination of direct immunomodulatory effects of combination antidiabetic therapies on T cells.

Main Results:

• T2D hallmarks like hyperglycemia, hyperinsulinemia, and dyslipidemia reprogram T cell metabolism.
• T cell functions, including immune responses and homeostasis, are compromised in T2D.
• Antidiabetic therapies exert direct immunomodulatory effects on T cells, influencing systemic metabolism.

Conclusions:

• Understanding the metabolic and immunomodulatory effects of T2D and its treatments is crucial.
• Restoring immune competence while maintaining immune balance requires addressing metabolic perturbations.
• Further research is needed to develop targeted therapeutic strategies for T2D that optimize immune function.